menu search

Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl

NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...

September 30, 2023, 8:46 pm

Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl

NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...

September 30, 2023, 8:46 pm

Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl

NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...

September 30, 2023, 8:46 pm

Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl

NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...

September 30, 2023, 8:46 pm

Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl

NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...

September 30, 2023, 8:46 pm

Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl

NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...

September 30, 2023, 8:46 pm

Is recursion pharmaceuticals stock a buy?

It has multiple programs in its pipeline, which focuses on rare diseases and cancer. Its use of artificial intelligence made the stock a hot buy earli...

September 30, 2023, 9:15 am

Thermo fisher: i'm waiting for a better valuation in this high-quality business

Thermo Fisher Scientific provides laboratory instruments, reagents, and consumables for scientific research and healthcare applications. These are the...

September 30, 2023, 4:02 am

Gsk: strong positioning and trading at historical discount

GSK is a leading biopharmaceutical company with a focus on vaccines and products for major diseases. GS...

September 29, 2023, 2:27 pm

Sharps technology announces closing of $5.6 million registered direct and private placement

NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical ...

September 29, 2023, 1:54 pm

Structure therapeutics stock soars on positive weight loss data

Structure Therapeutics Inc shares surged 34% to $50.34 in midday trading on Friday after the clinical-stage global bio...

September 29, 2023, 12:55 pm

Outlook therapeutics® requests type a meeting with fda

ISELIN, N.J., Sept. 29, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutic...

September 29, 2023, 12:05 pm

Are medical stocks lagging align technology (algn) this year?

Here is how Align Technology (ALGN) and Aurinia pharmaceuticals (AUPH) have performed compared to their...

September 29, 2023, 11:17 am

Avalyn to provide keynote presentation at the formulation & delivery u.s. 2023 conference

SEATTLE, Sept. 29, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical com...

September 29, 2023, 10:30 am

Why is tonix pharmaceuticals (tnxp) stock down 29% today?

Tonix pharmaceuticals (NASDAQ: TNXP ) stock is falling hard on Friday after the clinical-stage bio...

September 29, 2023, 9:17 am

Dyadic to present at industry and investor events in october

JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnolo...

September 29, 2023, 8:30 am

Theseus pharmaceuticals: picking up the pieces after a lead failure

Theseus pharmaceuticals experienced significant losses after discontinuing its lead program, leaving it...

September 29, 2023, 7:35 am

Poolbeg pharma closes chapter on patent challenge

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), the clinical-stage biopharmaceutical group, has announced t...

September 29, 2023, 2:47 am

Rosen, trusted national trial counsel, encourages infinity pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – infi

NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity ...

September 28, 2023, 9:00 pm

Regeneron to report third quarter 2023 financial and operating results and host conference call and webcast on november 2, 2023

TARRYTOWN, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) — Regeneron pharmaceuticals, Inc. (NASDAQ: REGN) tod...

September 28, 2023, 8:05 pm


Search within

Pages Search Results: